Combining Clenbuterol and Yohimbine creates a synergistic fat-burning effect by targeting both beta-2 and alpha-2 adrenergic receptors. Clenbuterol, a beta-2 agonist, promotes thermogenesis and increases metabolic rate, while Yohimbine, an alpha-2 antagonist, enhances fat mobilization from stubborn areas. Clenbuterol extends fat oxidation through beta-2 stimulation, and Yohimbine prevents fat storage by blocking alpha-2 receptors. Despite their effectiveness, the combination intensifies cardiovascular strain and can cause jitteriness, hypertension, and anxiety, necessitating cautious dosing.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Jabir, N.R., Firoz, C.K., Zughaibi, T.A., Alsaadi, M.A., Abuzenadah, A.M., Al-Asmari, A.I., Alsaieedi, A., Ahmed, B.A. and Ramu, A.K., 2022. A literature perspective on the pharmacological applications of yohimbine. Annals of Medicine.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Ultima-Helios 5.8 by Ultima Pharmaceuticals, consult with your doctor or healthcare professional.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Jabir, N.R., Firoz, C.K., Zughaibi, T.A., Alsaadi, M.A., Abuzenadah, A.M., Al-Asmari, A.I., Alsaieedi, A., Ahmed, B.A. and Ramu, A.K., 2022. A literature perspective on the pharmacological applications of yohimbine. Annals of Medicine.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Home
